A Look At ERAMET (ENXTPA:ERA) Valuation After Recent Share Price Weakness

Recent performance snapshot ERAMET (ENXTPA:ERA) has been on the radar after a period of mixed share price moves, with a small daily gain, a slight pullback over the past week, and a weaker past 3 ...

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

Adam Schayowitz, Ph.D., MBA appointed as Head of R&D • Scott Platshon appointed as Chief Business Officer VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), ...

Zymeworks Appoints Kristin Stafford as Chief Financial Officer

Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today ...